Your browser doesn't support javascript.
loading
Genomic Characterization of Metformin Hepatic Response.
Luizon, Marcelo R; Eckalbar, Walter L; Wang, Yao; Jones, Stacy L; Smith, Robin P; Laurance, Megan; Lin, Lawrence; Gallins, Paul J; Etheridge, Amy S; Wright, Fred; Zhou, Yihui; Molony, Cliona; Innocenti, Federico; Yee, Sook Wah; Giacomini, Kathleen M; Ahituv, Nadav.
Afiliação
  • Luizon MR; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, United States of America.
  • Eckalbar WL; Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America.
  • Wang Y; Department of General Biology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Jones SL; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, United States of America.
  • Smith RP; Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America.
  • Laurance M; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, United States of America.
  • Lin L; Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America.
  • Gallins PJ; School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
  • Etheridge AS; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, United States of America.
  • Wright F; Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America.
  • Zhou Y; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, United States of America.
  • Molony C; Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America.
  • Innocenti F; Library and Center for Knowledge Management, University of California San Francisco, San Francisco, California, United States of America.
  • Yee SW; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, United States of America.
  • Giacomini KM; Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, United States of America.
  • Ahituv N; Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
PLoS Genet ; 12(11): e1006449, 2016 Nov.
Article em En | MEDLINE | ID: mdl-27902686
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Fator 3 Ativador da Transcrição / Proteínas Quinases Ativadas por AMP / Proteínas Mutadas de Ataxia Telangiectasia / Fígado Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Fator 3 Ativador da Transcrição / Proteínas Quinases Ativadas por AMP / Proteínas Mutadas de Ataxia Telangiectasia / Fígado Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article